Genomic markers for neuroblastoma risk estimation: superseding tumor stage, age and MYCN?

Biomark Med. 2013 Dec;7(6):905-8. doi: 10.2217/bmm.13.97.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Biomarkers, Tumor / genetics
  • Child
  • Humans
  • Mutation
  • N-Myc Proto-Oncogene Protein
  • Neoplasm Staging
  • Neuroblastoma / genetics*
  • Neuroblastoma / pathology
  • Nuclear Proteins / genetics*
  • Oncogene Proteins / genetics*

Substances

  • Biomarkers, Tumor
  • MYCN protein, human
  • N-Myc Proto-Oncogene Protein
  • Nuclear Proteins
  • Oncogene Proteins